Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Podrid

Showing results (1-10 of 104) with videos related to

Pageof 11
Sort By:
Journal of Clinical Pharmacology|November 1, 1990
Pharmacologic therapy for arrhythmias: attention to the benefit-risk ratioP J Podrid
Cardiology Clinics|March 27, 1999
Atrial fibrillation in the elderlyP J Podrid
Annals of the New York Academy of Sciences|January 1, 1984
Role of higher nervous activity in ventricular arrhythmia and sudden cardiac death: implications for alternative antiarrhythmic therapyP J Podrid
Journal of Cardiovascular Pharmacology|January 1, 1991
Safety and toxicity of antiarrhythmic drug therapy: benefit versus riskP J Podrid
Pacing and Clinical Electrophysiology : PACE|November 1, 1990
Antiarrhythmic drug therapy: evaluation and modification of treatmentP J Podrid
European Heart Journal|September 1, 1989
Aggravation of arrhythmia: a complication of antiarrhythmic drug therapyP J Podrid
Annals of Internal Medicine|August 1, 1989
Resuscitation in the elderly: a blessing or a curse?P J Podrid
Chest|September 1, 1985
Antiarrhythmic drug therapy (Part 1). Benefits and hazardsP J Podrid
Postgraduate Medicine|December 31, 1997
Arrhythmias after acute myocardial infarction. Evaluation and management of rhythm and conduction abnormalitiesP J Podrid
The American Journal of Cardiology|March 6, 1990
Potassium and ventricular arrhythmiasP J Podrid
Pageof 11

Showing results (1-10 of 104) with videos related to

Sort By:
Pageof 11
Journal of Clinical Pharmacology|November 1, 1990
Pharmacologic therapy for arrhythmias: attention to the benefit-risk ratioP J Podrid
Cardiology Clinics|March 27, 1999
Atrial fibrillation in the elderlyP J Podrid
Annals of the New York Academy of Sciences|January 1, 1984
Role of higher nervous activity in ventricular arrhythmia and sudden cardiac death: implications for alternative antiarrhythmic therapyP J Podrid
Journal of Cardiovascular Pharmacology|January 1, 1991
Safety and toxicity of antiarrhythmic drug therapy: benefit versus riskP J Podrid
Pacing and Clinical Electrophysiology : PACE|November 1, 1990
Antiarrhythmic drug therapy: evaluation and modification of treatmentP J Podrid
European Heart Journal|September 1, 1989
Aggravation of arrhythmia: a complication of antiarrhythmic drug therapyP J Podrid
Annals of Internal Medicine|August 1, 1989
Resuscitation in the elderly: a blessing or a curse?P J Podrid
Chest|September 1, 1985
Antiarrhythmic drug therapy (Part 1). Benefits and hazardsP J Podrid
Postgraduate Medicine|December 31, 1997
Arrhythmias after acute myocardial infarction. Evaluation and management of rhythm and conduction abnormalitiesP J Podrid
The American Journal of Cardiology|March 6, 1990
Potassium and ventricular arrhythmiasP J Podrid
Pageof 11